Strategic Program Plan 2021-24
Harnessing the capabilities of our members to position Victoria as a trailblazer in research-led, consumer-engaged, cancer education, prevention, detection, treatment and care.
The VCCC Alliance is a powerful partnership between 10 leading research, academic and clinical institutions working together to expedite and amplify leading-edge cancer research, knowledge and expertise to improve outcomes for people affected by cancer.
Through innovation and collaboration, our alliance is leading integrated, research-driven, consumer-informed cancer research, education and patient care. By capitalising on our collective strengths, we are fundamentally changing the way we tackle cancer and accelerating the translation of scientific evidence into patient benefit.
The new VCCC Alliance Strategic Program Plan 2021-24 is a roadmap of integrated, innovative and ambitious programs designed to tackle the complexities and inequities of cancer outcomes in Victoria. Read more and discover the 10 programs that aim to shift the dial in key areas of need and opportunity over the next three years.
VCCC Alliance Strategic Program Plan 2021-24
This week, we hosted two gatherings that gave a real sense of the progress we are making on the strategic vision for this world-class cancer alliance.
The Annual General Meeting held this morning was a great chance to take stock of what has been achieved in a challenging but exciting year for us. And earlier this week, the Distributed Leadership Summit was a rare chance to get a helicopter view of how our collective impact model works in practice. I regularly endorse this unique leadership model as the key to getting things done in the alliance. It is a view that is reinforced whenever we get together.
A new initiative driven by the Research and Education Lead (R&E Lead) Sarcoma program is seeking to improve access to novel sarcoma diagnostic pipelines leading to better diagnoses and treatment options for patients with sarcoma.
An inaugural meeting in August brought together pathologists with expertise in sarcoma from Victorian institutions, including St Vincent’s Hospital Melbourne, Peter MacCallum Cancer Centre, The Royal Children’s Hospital and Monash Health, in both the paediatric and adult sarcoma space.
A recent article, Diversity in clinical trials: an opportunity and imperative for community engagement has been published in The Lancet.
The authors propose a community engagement model that may prove useful when addressing similar problems in Australia.
The theme for the 2020-21 Annual Report is The Great Reset, reflecting the progression from our Strategic Research Plan 2017-20 to our new Strategic Program Plan, overlaid by our experiences and lessons as research, health and academic institutions during a pandemic.
In FY 20/21, the remaining objectives for the Strategic Research Plan 2017-20 were realised and the final evaluation was submitted to the Victorian Department of Health in October 2020.
A groundbreaking study emerging from the Centre for Cancer Immunotherapy (CCI) – a joint initiative between the Peter MacCallum Cancer Centre, the University of Melbourne and the VCCC Alliance – has become the latest achievement for the innovative collaboration.
SAFRON II, led by Peter MacCallum Cancer Centre’s Associate Professor Shankar Siva and funded through the VCCC Alliance, addresses a previously unresolved question around the most efficient way to deliver Stereotactic Ablative Radiotherapy (SABR) to patients with low volume metastatic (oligometastatic) pulmonary disease.
Incidental detection of prostate cancer with computed tomography scans
Artificial Intelligence (AI) and computer vision are gaining popularity as decision support tools for cancer diagnosis and intervention. As a result, they have opened up innovative opportunities in the early detection of cancer.
National Breast Cancer Foundation; our vision towards zero deaths
Join the Director of Research Investment at the National Breast Cancer Foundation (NBCF), who will provide an overview of her journey leading to her appointment at NBCF, her vision for the future of breast cancer, and research and funding opportunities currently available.
Antiviral treatments for COVID-19 – the role of CRISPR-Cas13
Victorian researchers have embarked on groundbreaking research to potentially stop COVID-19 from replicating in infected human cells using advancements in gene editing. This is a major step towards treatment for COVID-19 and its variants. Join Professor Sharon Lewin, Dr Mohamed Fareh and Dr Wei Zhao for front-row insights into fighting novel viruses into the future.
The VCCC Alliance is seeking an Evaluation Manager to join our team to further develop and lead the operationalisation of our program logic-based evaluation framework. The framework has been developed to monitor progress and evaluate the impact of strategic goals and specific programs of work to enable effective monitoring and evaluation of the VCCC Alliance Strategic Program Plan, 2020-24.
WEHI will offer four-week paid research placements for medical students in the 2021-2022 summer vacation period.
Vacation scholarships allow medical students to get hands-on experience in medical research, through working as part of leading research teams.
WEHI's International PhD Scholar Initiative recruits outstanding candidates from outside of Australia to join the Medical Biology PhD Program.
Research projects are available in cancer, immunology, infectious diseases, developmental biology, age-related disorders, computational biology, advanced technologies and drug discovery.
The initiative provides dedicated scholarships that include a living allowance, a $2000 per annum scholarship top-up plus a relocation allowance, health insurance coverage, and a university tuition fee offset.
